Drug class in one race
Insulin receptor (basal) drugs for Type 2 Diabetes
20 tracked Insulin receptor (basal) drugs in the Type 2 Diabetes race. The class explanation lives on the Insulin receptor (basal) page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
10 approved / phase 46 Phase 32 Phase 22 Phase 1
Head-to-head evidence: Afrezza vs AT278 · AT278 vs GZR101 · AT278 vs GZR33 · AT278 vs INS068 · AT278 vs IcoSema · AT278 vs Insulin Efsitora Alfa